Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Ocuphire Announces Enrollment Of First Patients In Second Phase 3 Pivotal Trial (MIRA-3) For Nyxol In Reversal of Mydriasis


Benzinga | Nov 23, 2021 09:04AM EST

Ocuphire Announces Enrollment Of First Patients In Second Phase 3 Pivotal Trial (MIRA-3) For Nyxol In Reversal of Mydriasis






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC